Clinical audit of anticoagulant therapy with pregnancy

Background and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy. Clinical audit can be defined as the process of asses...

Full description

Bibliographic Details
Main Authors: Mahmoud I El-Rasheedy, Ahmed H Mohammed, Asmaa M Mahmoud
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=3;spage=363;epage=369;aulast=El-Rasheedy
id doaj-8d18ea1c38704009872ee823e2b5f642
record_format Article
spelling doaj-8d18ea1c38704009872ee823e2b5f6422021-04-20T08:32:18ZengWolters Kluwer Medknow PublicationsAl-Azhar Assiut Medical Journal1687-16932020-01-0118336336910.4103/AZMJ.AZMJ_96_20Clinical audit of anticoagulant therapy with pregnancyMahmoud I El-RasheedyAhmed H MohammedAsmaa M MahmoudBackground and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy. Clinical audit can be defined as the process of assessment through the use of evidence-based criteria and/or the outcome of care by comparison with others. In the current study, the aim was to audit the anticoagulant therapy usage in pregnancy and compared it with the chosen international standards (RCOG standards). Patients and methods The study was done at Gynecology and Obstetrics Department of Minia General Hospital, Egypt, on 300 pregnant women on anticoagulant therapy. Results Regarding the percent of patients following the international guidelines among the 300 studied cases on anticoagulant therapy, 174 (58%) cases agreed with RCOG guidelines and 126 (42%) did not agree with RCOG guidelines. Conclusion The use of anticoagulant in pregnancy must be balanced according to the benefit and the risks of use.http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=3;spage=363;epage=369;aulast=El-Rasheedyanticoagulant therapyclinical auditpregnant womenrcog standards
collection DOAJ
language English
format Article
sources DOAJ
author Mahmoud I El-Rasheedy
Ahmed H Mohammed
Asmaa M Mahmoud
spellingShingle Mahmoud I El-Rasheedy
Ahmed H Mohammed
Asmaa M Mahmoud
Clinical audit of anticoagulant therapy with pregnancy
Al-Azhar Assiut Medical Journal
anticoagulant therapy
clinical audit
pregnant women
rcog standards
author_facet Mahmoud I El-Rasheedy
Ahmed H Mohammed
Asmaa M Mahmoud
author_sort Mahmoud I El-Rasheedy
title Clinical audit of anticoagulant therapy with pregnancy
title_short Clinical audit of anticoagulant therapy with pregnancy
title_full Clinical audit of anticoagulant therapy with pregnancy
title_fullStr Clinical audit of anticoagulant therapy with pregnancy
title_full_unstemmed Clinical audit of anticoagulant therapy with pregnancy
title_sort clinical audit of anticoagulant therapy with pregnancy
publisher Wolters Kluwer Medknow Publications
series Al-Azhar Assiut Medical Journal
issn 1687-1693
publishDate 2020-01-01
description Background and aim Anticoagulant use in pregnant women should be paid great attention in both the period of pregnancy and the postpartum period. Risks and benefits to the mother and fetus should be balanced in the choice of anticoagulant therapy. Clinical audit can be defined as the process of assessment through the use of evidence-based criteria and/or the outcome of care by comparison with others. In the current study, the aim was to audit the anticoagulant therapy usage in pregnancy and compared it with the chosen international standards (RCOG standards). Patients and methods The study was done at Gynecology and Obstetrics Department of Minia General Hospital, Egypt, on 300 pregnant women on anticoagulant therapy. Results Regarding the percent of patients following the international guidelines among the 300 studied cases on anticoagulant therapy, 174 (58%) cases agreed with RCOG guidelines and 126 (42%) did not agree with RCOG guidelines. Conclusion The use of anticoagulant in pregnancy must be balanced according to the benefit and the risks of use.
topic anticoagulant therapy
clinical audit
pregnant women
rcog standards
url http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=3;spage=363;epage=369;aulast=El-Rasheedy
work_keys_str_mv AT mahmoudielrasheedy clinicalauditofanticoagulanttherapywithpregnancy
AT ahmedhmohammed clinicalauditofanticoagulanttherapywithpregnancy
AT asmaammahmoud clinicalauditofanticoagulanttherapywithpregnancy
_version_ 1721518306133803008